Sunrest Lifescience (NSE:SUNREST) Debt-to-Equity : 0.43 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Sunrest Lifescience Debt-to-Equity?

Sunrest Lifescience's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹27.0 Mil. Sunrest Lifescience's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹34.6 Mil. Sunrest Lifescience's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹141.9 Mil. Sunrest Lifescience's debt to equity for the quarter that ended in Mar. 2024 was 0.43.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Sunrest Lifescience's Debt-to-Equity or its related term are showing as below:

NSE:SUNREST' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.43 Med: 3.02 Max: 17.54
Current: 0.43

During the past 5 years, the highest Debt-to-Equity Ratio of Sunrest Lifescience was 17.54. The lowest was 0.43. And the median was 3.02.

NSE:SUNREST's Debt-to-Equity is ranked better than
51.16% of 559 companies
in the Healthcare Providers & Services industry
Industry Median: 0.44 vs NSE:SUNREST: 0.43

Sunrest Lifescience Debt-to-Equity Historical Data

The historical data trend for Sunrest Lifescience's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunrest Lifescience Debt-to-Equity Chart

Sunrest Lifescience Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Equity

17.54

7.85

3.02

0.69

0.43

Sunrest Lifescience Quarterly Data
	Mar20	Mar21	Mar22	Mar23	Mar24
Debt-to-Equity	17.54	7.85	3.02	0.69	0.43

Competitive Comparison of Sunrest Lifescience's Debt-to-Equity

For the Pharmaceutical Retailers subindustry, Sunrest Lifescience's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sunrest Lifescience's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sunrest Lifescience's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Sunrest Lifescience's Debt-to-Equity falls into.

Sunrest Lifescience Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Sunrest Lifescience's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(26.979	+	34.618)	/	141.854
	=	0.43

Sunrest Lifescience's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(26.979	+	34.618)	/	141.854
	=	0.43

Sunrest Lifescience (NSE:SUNREST) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Sunrest Lifescience Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Sunrest Lifescience's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Sunrest Lifescience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sunrest Lifescience Ltd (NSE:SUNREST) » Definitions » Debt-to-Equity

Traded in Other Exchanges

N/A

Address

Vastral Road, FF-41, Ajay Tenament-6 Near Canal, Near Ritanagar Bus Stand, Ahmedabad, GJ, IND, 382415

Website

https://www.sunrestlifescience.com

Sunrest Lifescience Ltd is engaged in the trading business of pharmaceutical products on a wholesale and retail basis. It deals in Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste. Its product portfolio comprises Analgesic & Anti Pyretic3030, Antacid Anti Emetics1414, Anti Biotics1717, Anti Cough & Cold4343, Anti Fungal2929, Anti Spasmodic & Enzyme99, Creams & Ointments44, Eye, Ear Drops & Nasal Spray88, General Products2828, Glucose & Energy Drink88, Hair Care77, Lady Care55, Multi Vitamins & Haemantinics3030, Oral Care55, Skin Care2222, and Vigor and Vitality.

Sunrest Lifescience Headlines

No Headlines